Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

TSX:EDT - Post Discussion

View:
Post by oilandgasman on Feb 22, 2024 11:59am

Data

My phone when in and out a few times during the call, did Baxter even look at the Spectral data?
Or was Baxter seeing the data another potental red flag from the FDA post 150?

over all a very weird call.
Comment by palinc2000 on Feb 22, 2024 12:16pm
Baxter did not exercise its right to access thr data,,,,,,weird!!
Comment by hmmmmmmmm on Feb 22, 2024 12:47pm
As per pg 14 and 18 of the Anual Meeting Presentation: "At 90 patients Baxter will have access to raw data (no statistical analysis)… potential opportunity to release crude data to broader audience" "Spectral Catalysts • Tigris interim patient enrollment - 90 patients / Baxter milestone payment #2 • Release of crude mortality data at 90 patients" https://spectraldx.com/wp ...more  
Comment by gebremeskel on Feb 22, 2024 1:01pm
On the call they talked about Baxter not wanting to take the "risk" of looking at data and the danger of released data being construed as an "interim analysis"  that might somehow affect later FDA deliberations. They talked about bad optics and the possibility of a "data penalty" I wonder if there is a more knowledgable poster on the board who would be willing ...more  
Comment by oilandgasman on Feb 23, 2024 9:56am
I 100% believe Baxter has seen the data …I call BS
Comment by hmmmmmmmm on Feb 23, 2024 12:14pm
I agree that Baxter have seen the data- and they saw it early/  around 82. So why would they cover it up and deny it? And are there any of the many who want to blow the whistle? Feel free to PM..
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities